Expressional profiling and clinical relevance of RNase κ in prostate cancer: a novel indicator of favorable progression-free survival.
Athina Kladi-SkandaliKonstantinos MavridisAndreas ScorilasDiamantis C SiderisPublished in: Journal of cancer research and clinical oncology (2018)
RNase κ is a biomarker of favorable prognosis in CaP, which is significantly associated with less advanced and aggressive disease, as well as with enhanced PFS.